Commentary: A new hope: Do ADAURA trial results change the paradigm for treatment of resectable lung adenocarcinoma?

J Thorac Cardiovasc Surg. 2021 Jul;162(1):293-294. doi: 10.1016/j.jtcvs.2021.02.073. Epub 2021 Feb 26.

Authors

Sue Xue Wang¹, M Blair Marshall²

Affiliations

¹ Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass.
² Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Mass. Electronic address: mmarshall16@bwh.harvard.edu.

PMID: 33863497
DOI: 10.1016/j.jtcvs.2021.02.073

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adenocarcinoma of Lung* / surgery
Humans
Lung Neoplasms* / surgery
Pancreatic Neoplasms*